I think that management probably are not to worried about the day to day SP even the SP on a monthly basis,
my reason for saying this is management are trying to create a global company and possibly have the opinion of ALL or NOTHING with this strategy.
Lets face it
Option 1, they are successful and hit their targets. They will have been paid handsomely through the process and will pick up huge performance bonuses along the way to offset any further dilution.
Option 2, the product is great but the company struggles through mismanagement. They are still paid handsomely and milk the company for any and all benefits, while screwing shareholders, potentially for years.
Option 3, the company folds. They still have been paid handsomely, and will probably pick up another role with another listed company because they tried really hard.
So my conclusion is, while management are PAID so well and have access to not only stock as BONUSES but the ability to go back to the market and raise more money at any cost, shareholders are at their mercy. But please don't believe that investing in any one of these start up companies is any better than gambling, because no matter how much you believe the management are out there for you, THEIR NOT.
My opinion on any management would only change if they threw their own money in to become shareholders and not to become shareholders by stock gifting through bonuses.
Most listed companies are like government departments, if they spend all there allotted money this year they ask for more next year.
In saying all this, I really hope this management can pull this off without to much further dilution, but I have a medium to long term view on this one, I have a fare amount on the table with this one that will hurt if lost, but wont be the end me.(the wife will be pissed though)
The one positive thing about AHZ management, is they have been able to achieve all their targets to date, and their not out there spinning stories.
Good luck all
- Forums
- ASX - By Stock
- AVR
- News: Admedus receives A$0.22 price target from Morgans
News: Admedus receives A$0.22 price target from Morgans, page-85
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.00 |
Change
-0.150(1.48%) |
Mkt cap ! $211.3M |
Open | High | Low | Value | Volume |
$10.26 | $10.35 | $9.80 | $295.8K | 29.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22 | $9.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.00 | 2758 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22 | 9.870 |
1 | 1000 | 9.860 |
1 | 2000 | 9.850 |
2 | 4587 | 9.800 |
1 | 200 | 9.600 |
Price($) | Vol. | No. |
---|---|---|
10.000 | 2758 | 1 |
10.490 | 198 | 1 |
10.500 | 10000 | 1 |
11.000 | 3000 | 1 |
11.500 | 250 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online